Aldeyra Therapeutics, Inc. Made Headway

Aldeyra Therapeutics, Inc. (ALDX:NASDAQ) soared at $2.54, a gain of 48.5%. On Wed, Nov 01, 2023, ALDX:NASDAQ hit a New 2-Week High of $2.54. The stock appeared on our News Catalysts scanner on Wed, Nov 01, 2023 at 09:00 AM in the 'AGREEMENT' category. From Wed, Oct 18, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days

The stock spiked on Thu, Jun 15, 2023 at $11.97 with a volume of 2M+.

About Aldeyra Therapeutics, Inc. (ALDX:NASDAQ)

Aldeyra Therapeutics Inc is biotechnology company focused on the development of products for inflammation, inborn errors of metabolism, and other diseases, related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes.